Free Trial

Veritone (VERI) Competitors

Veritone logo
$1.48 -0.04 (-2.63%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$1.50 +0.02 (+1.69%)
As of 06:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERI vs. MXCT, III, TCX, OABI, PESI, AHG, RGP, RCMT, EDHL, and MIMI

Should you be buying Veritone stock or one of its competitors? The main competitors of Veritone include MaxCyte (MXCT), Information Services Group (III), Tucows (TCX), OmniAb (OABI), Perma-Fix Environmental Services (PESI), Akso Health Group (AHG), Resources Connection (RGP), RCM Technologies (RCMT), Everbright Digital (EDHL), and Mint Incorporation (MIMI). These companies are all part of the "business services" industry.

Veritone vs. Its Competitors

MaxCyte (NASDAQ:MXCT) and Veritone (NASDAQ:VERI) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Veritone has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Veritone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte$38.63M6.12-$41.06M-$0.40-5.55
Veritone$92.64M0.76-$37.38M-$0.88-1.68

68.8% of MaxCyte shares are owned by institutional investors. Comparatively, 39.2% of Veritone shares are owned by institutional investors. 3.3% of MaxCyte shares are owned by insiders. Comparatively, 26.6% of Veritone shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

MaxCyte presently has a consensus target price of $7.50, suggesting a potential upside of 237.84%. Veritone has a consensus target price of $4.50, suggesting a potential upside of 204.05%. Given MaxCyte's stronger consensus rating and higher probable upside, research analysts clearly believe MaxCyte is more favorable than Veritone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MaxCyte
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Veritone
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, Veritone had 5 more articles in the media than MaxCyte. MarketBeat recorded 5 mentions for Veritone and 0 mentions for MaxCyte. Veritone's average media sentiment score of 0.12 beat MaxCyte's score of 0.00 indicating that Veritone is being referred to more favorably in the news media.

Company Overall Sentiment
MaxCyte Neutral
Veritone Neutral

Veritone has a net margin of -32.75% compared to MaxCyte's net margin of -110.92%. Veritone's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-110.92% -19.90% -17.24%
Veritone -32.75%N/A -15.69%

MaxCyte has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Veritone has a beta of 2.64, meaning that its stock price is 164% more volatile than the S&P 500.

Summary

Veritone beats MaxCyte on 11 of the 16 factors compared between the two stocks.

Get Veritone News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERI vs. The Competition

MetricVeritoneTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$72.28M$2.39B$13.06B$8.95B
Dividend YieldN/A1.41%2.71%4.04%
P/E Ratio-1.6831.3328.6620.11
Price / Sales0.7635.0439.76119.84
Price / CashN/A43.9426.6257.86
Price / Book4.485.846.235.56
Net Income-$37.38M$32.07M$188.58M$248.40M
7 Day Performance4.23%2.71%2.47%4.67%
1 Month Performance-6.33%3.57%3.21%6.64%
1 Year Performance-47.14%58.47%39.11%21.31%

Veritone Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERI
Veritone
3.6325 of 5 stars
$1.48
-2.6%
$4.50
+204.1%
-46.8%$72.28M$92.64M-1.68550
MXCT
MaxCyte
2.6252 of 5 stars
$2.18
-0.9%
$7.50
+244.0%
-45.2%$232.00M$38.63M-5.4580Positive News
III
Information Services Group
2.3506 of 5 stars
$4.80
+3.2%
$5.50
+14.6%
+73.1%$231.38M$242.90M32.001,323Analyst Downgrade
High Trading Volume
TCX
Tucows
0.7078 of 5 stars
$19.71
+1.2%
N/A+15.7%$217.99M$362.27M-2.141,000
OABI
OmniAb
2.584 of 5 stars
$1.74
+2.4%
$7.00
+302.3%
-47.2%$212.52M$26.39M-3.007Positive News
PESI
Perma-Fix Environmental Services
0.3072 of 5 stars
$10.52
+0.9%
N/A+35.4%$194.12M$59.42M-8.42290
AHG
Akso Health Group
0.9651 of 5 stars
$1.30
+7.4%
N/A+26.5%$189.44M$2.41M0.0040News Coverage
Positive News
RGP
Resources Connection
1.4549 of 5 stars
$5.37
-1.6%
$5.00
-6.9%
-41.7%$177.59M$632.80M-1.643,376
RCMT
RCM Technologies
3.2214 of 5 stars
$23.57
+2.0%
$33.50
+42.1%
+45.4%$174.42M$278.38M13.623,140
EDHL
Everbright Digital
N/A$5.99
-0.7%
N/AN/A$159.69M$2.76M0.007
MIMI
Mint Incorporation
N/A$6.62
-6.2%
N/AN/A$150.61MN/A0.0015Lockup Expiration
High Trading Volume

Related Companies and Tools


This page (NASDAQ:VERI) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners